CTOs on the Move

Boston MicroFluidics

www.bostonmicrofluidics.com

 
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Boston MicroFluidics raised $17.5M on 08/27/2019

Similar Companies

Medaudit Services Inc

Medaudit Services Inc is a Midland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Horizon Bay Retirement Living

Horizon Bay Retirement Living is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tampa, FL. To find more information about Horizon Bay Retirement Living, please visit www.horizonbay.com

NetMD Business

NetMD Business is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WellDoc

WellDoc is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iRhythm

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.